These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26942018)

  • 1. Developmental Dynamics of Rett Syndrome.
    Feldman D; Banerjee A; Sur M
    Neural Plast; 2016; 2016():6154080. PubMed ID: 26942018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
    Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
    PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
    Pohodich AE; Zoghbi HY
    Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.
    Medrihan L; Tantalaki E; Aramuni G; Sargsyan V; Dudanova I; Missler M; Zhang W
    J Neurophysiol; 2008 Jan; 99(1):112-21. PubMed ID: 18032561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of MeCP2 loss- or gain-of-function on synaptic plasticity.
    Na ES; Nelson ED; Kavalali ET; Monteggia LM
    Neuropsychopharmacology; 2013 Jan; 38(1):212-9. PubMed ID: 22781840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.
    Armstrong DD; Deguchi K; Antallfy B
    J Child Neurol; 2003 Oct; 18(10):683-7. PubMed ID: 14649549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of Rett syndrome.
    Akbarian S
    Neuroscientist; 2003 Feb; 9(1):57-63. PubMed ID: 12580340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
    Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
    Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.
    Zhou Z; Hong EJ; Cohen S; Zhao WN; Ho HY; Schmidt L; Chen WG; Lin Y; Savner E; Griffith EC; Hu L; Steen JA; Weitz CJ; Greenberg ME
    Neuron; 2006 Oct; 52(2):255-69. PubMed ID: 17046689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome.
    Santos M; Summavielle T; Teixeira-Castro A; Silva-Fernandes A; Duarte-Silva S; Marques F; Martins L; Dierssen M; Oliveira P; Sousa N; Maciel P
    Neuroscience; 2010 Oct; 170(2):453-67. PubMed ID: 20633611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
    Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.
    Weng SM; McLeod F; Bailey ME; Cobb SR
    Neuroscience; 2011 Apr; 180():314-21. PubMed ID: 21296130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MECP2 and beyond: phenotype-genotype correlations in Rett syndrome.
    Christodoulou J; Weaving LS
    J Child Neurol; 2003 Oct; 18(10):669-74. PubMed ID: 14649547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of GABA
    Oyarzabal A; Xiol C; Castells AA; Grau C; O'Callaghan M; Fernández G; Alcántara S; Pineda M; Armstrong J; Altafaj X; García-Cazorla A
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rett syndrome and neuronal development.
    Johnston MV; Blue ME; Naidu S
    J Child Neurol; 2005 Sep; 20(9):759-63. PubMed ID: 16225832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rett syndrome: of girls and mice--lessons for regression in autism.
    Glaze DG
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.